• • OCTOBER 9, 2026
  • 0 COMMENTS
  

  Cancer is not to be feared; what is truly frightening is losing faith.

  In a ward at Guangzhou Taihe Cancer Hospital, 74-year-old Mr Chen (a pseudonym) still stands tall. His journey of fighting cancer, which has lasted more than eight months, has been another gruelling battle in this Vietnam War veteran’s life, following his time on the battlefield defending his country. Unlike the smoke-filled clashes of war, this time the enemy he must confront is a malignant tumour lurking within his own body.

  Hidden lesions masquerading as laryngitis

  The prelude to this battle against cancer began during the Spring Festival of 2024, the Year of the Dragon. Whilst the family was gathered together, Mr Chen suddenly experienced discomfort in his throat; the initial symptoms were diagnosed as a common case of laryngitis. After returning home, Mr Chen continued to follow a treatment regimen tailored to laryngitis, but his symptoms showed no sign of improvement.
  Subsequent comprehensive and systematic examinations revealed the true cause of his illness: Mr Chen was diagnosed with a primary malignant tumour of the oesophagus, accompanied by a secondary malignant tumour in the liver, indicating that the cancer had metastasised.
  Due to the presence of metastases and the complexity of his condition, coupled with Mr Chen’s history of diabetes and previous coronary artery bypass surgery, conventional surgical treatment options could not be pursued. The news of his diagnosis came as a sudden and profound shock, but Mr Chen—a man hardened by the trials of war—quickly regained his composure after a brief period of adjustment and faced his illness head-on with an unwavering will to survive.

  Waiting calmly for the military parade to end, then going into hospital for treatment at his own pace

  Faced with a life-or-death ordeal, Mr Chen demonstrated extraordinary rationality and resilience. After his family and Mr Chen had thoroughly researched the options and sought advice from various sources, they identified proton therapy—a cutting-edge technique in China that causes minimal physical damage—and ultimately chose Guangzhou Taihe Cancer Hospital for his treatment. Determined to seize this best chance of recovery, Mr Chen resolved to use his entire retirement savings to fight the disease with all his might.
  On the eve of his admission, Mr Chen made a special request to the hospital to postpone his treatment. At that time, the military parade marking the 80th anniversary of the victory in the War of Resistance was imminent; as a veteran who had experienced the horrors of war first-hand, witnessing this grand ceremony was a deeply cherished wish of his. This profound sense of patriotism, deeply ingrained in his heart, served as the spiritual strength that sustained him and represented the unique honour of a veteran.
  Mr Chen watched the 80th-anniversary military parade commemorating the victory in the War of Resistance against Japanese Aggression with solemn reverence from start to finish. Only after fulfilling this heartfelt wish did he admit himself to hospital as scheduled to formally commence standardised cancer treatment.

  Faith as a Shield Against Illness: A Veteran’s Resolve Continues to Work Miracles of Life

  His many years of military service forged in Mr Chen a tenacious spirit characterised by a refusal to shy away from hardship, a fearlessness in the face of adversity, and a refusal to admit defeat. This military ethos, ingrained in his very being, has become his greatest source of mental strength in his battle against illness. Throughout his cancer treatment, no matter what discomfort or hardship he faced, Mr Chen remained composed and steadfast, always firmly believing that cancer itself is not to be feared; what truly defeats a person is the loss of hope and the abandonment of inner resolve.
  In his earlier years, Mr Chen underwent coronary bypass surgery following a heart attack. After the operation in 2010, doctors predicted that he had only eight to ten years left to live. Through sheer willpower and a disciplined lifestyle, he not only surpassed that prognosis but lived on peacefully for a further sixteen years. Faced with this serious illness, Mr Chen remained steadfast in his resolve, cooperating fully with his medical team and holding fast to the conviction that continued treatment offered hope of recovery.

  Targeted treatment proves effective: pain is alleviated and hope for a better life is rekindled

  Mr Chen has now successfully completed proton therapy for his oesophageal cancer. Prior to his admission, Mr Chen had severe difficulty swallowing due to the tumour, and could only manage to consume liquid foods such as millet porridge; even the slightest amount of solid food would trigger symptoms such as dysphagia and vomiting, which had taken a heavy toll on his physical condition.
  Following more than twenty sessions of precision proton therapy, Mr Chen’s symptoms of dysphagia have significantly improved and his physical functions have gradually recovered. He is now able to eat regular foods such as rice, noodles and meat, and his quality of life has improved markedly.
  Mr Chen has clear plans for the future: after discharge, he intends to undergo long-term treatment with traditional Chinese medicine to steadily recuperate and return to a peaceful life in his later years.
  Speaking to the camera, Mr Chen offered words of encouragement to all patients battling illness: with today’s advanced medical technology and comprehensive healthcare policies, what patients need most is to hold fast to their resolve, maintain a positive outlook at all times, and actively cooperate with medical staff in their treatment; in doing so, they will ultimately see the light at the end of the tunnel.

  Read more

  • chinameds
  • Uncategorized
• • OCTOBER 7, 2026
  • 0 COMMENTS
  

  Nine-Year Battle to Complete Remission: A Relapsed/Refractory Follicular Lymphoma Patient’s Journey to New Life

  Mr. Yang, a 49-year-old patient from Beijing, suffered from follicular lymphoma. Over the years following his diagnosis, he underwent multiple rounds of chemotherapy, targeted therapy, bispecific antibody therapy, CAR-T therapy, and various clinical trials; despite these efforts, he endured a grueling, nine-year battle against the disease, marked by a fluctuating condition, repeated relapses, and severe pulmonary complications. After treatments from various sources yielded limited results and his physical condition continued to deteriorate, Mr. Yang was referred to the Department of Lymphoma and Myeloma at Beijing Gaobo Hospital. There, through a regimen of systematic care and a novel CAR-T clinical trial, he ultimately achieved complete remission of tumors throughout his body, successfully concluding his arduous nine-year struggle.

  01 Sudden Diagnosis: First-Round Treatment Plagued by Relapse

  Mr. Yang developed swollen neck lymph nodes without any apparent trigger. Medical examinations, including a CT scan, revealed abnormal lymph node enlargement throughout his body; subsequent pathological testing confirmed a diagnosis of Grade 3b follicular lymphoma. Upon receiving this sudden diagnosis of a malignant tumor, he was devastated and struggled to come to terms with his illness.
  Immediately following the diagnosis, Mr. Yang began a standardized treatment regimen, completing eight cycles of R-CHOP chemotherapy. While he tolerated the initial rounds reasonably well and saw significant early results, he failed to achieve complete clinical remission and had to rely on targeted therapy to maintain disease stability. Regrettably, the lymph node masses recurred just three months after treatment ended; this relapse dealt a severe psychological blow. However, with the encouragement and support of his family, Mr. Yang quickly regained his composure, actively sought new treatment options, and remained committed to fighting the cancer.

  02 Nine Years of Seeking Treatment: Relapses and Severe Complications

  Over the nine years following his diagnosis, Mr. Yang sought care at various hospitals in Beijing and exhausted all mainstream anti-tumor treatments, including chemotherapy, targeted therapy, bispecific antibody therapy, CAR-T therapy, and multiple cutting-edge clinical trials. Although each treatment initially yielded rapid results and effectively controlled the disease, drug resistance would quickly develop, leading to repeated relapses and preventing a permanent cure.
  The long-term, repetitive treatments and the progression of the disease took a heavy toll on Mr. Yang’s physical health. Following a viral infection, the tumor metastasized to his lungs, marking the most difficult phase of his battle against the illness. He suffered from recurrent pulmonary infections and persistent high fevers, experiencing bouts of pneumonia every month; the long-term use of immunosuppressants further compromised his immune system, creating a vicious cycle that made the lung infections difficult to cure.
  At one point during his treatment, a severe bacterial infection triggered critical pneumonia. His condition became life-threatening—to the extent that the local hospital issued a critical illness notice—and his condition was stabilized only after emergency intervention. He was subsequently transferred to the ICU due to a severe pulmonary infection; after nearly a month of shuttling between the ICU and general wards, he finally moved past the critical stage.
  Despite recurring illness and the physical torment caused by the disease, Mr. Yang maintained a positive mindset. He persisted with moderate exercise and lifestyle adjustments, calmly coexisting with the illness while never abandoning hope for recovery.

  03 Referral to Gaobo Hospital: Precision Care Breaks the Treatment Impasse

  Prolonged recurrence and the continued progression of his pulmonary tumor caused Mr. Yang to suffer from persistent, violent coughing; he was unable to wean off high-flow oxygen therapy and was physically extremely frail. With no breakthroughs achieved through conventional treatments, a leading hematology expert recommended he visit Beijing Gaobo Hospital. The goal was to seek a personalized treatment plan by leveraging the hospital’s research-driven clinical capabilities and the department’s extensive experience in treating relapsed and refractory lymphoma.
  Mr. Yang consulted Director Ke Xiaoyan at the Department of Lymphoma and Myeloma at Beijing Gaobo Hospital. The medical team conducted a detailed review of his medical records, treatment history, and the progression of his condition over the years. Given the complexity of his case—characterized by severe progression of pulmonary lesions, multidrug resistance, and recurrent infections—the expert team identified shortcomings in his previous treatments, specifically a lack of variety and a failure to implement a systematic, comprehensive approach. Despite the critical nature of his condition and the extensive invasion of the pulmonary lesions, the team decided to admit him and formulate a personalized rescue treatment plan.
  Upon admission, Director Hu Kai’s team conducted a comprehensive review of the patient’s entire treatment history and physiological indicators. By meticulously organizing medical records and precisely assessing the condition, they rapidly finalized a brand-new, comprehensive treatment plan. Within just one week of standardized treatment, positive results emerged: the patient’s lung function improved significantly, he successfully weaned off the high-flow oxygen support he had long relied upon, and his overall physical condition began to recover.
  During the subsequent course of treatment, as the patient faced recurring adverse reactions—such as infections and fevers—and fluctuations in his condition, Director Hu Kai’s team dynamically adjusted the treatment plan, precisely managed various complications, and maintained careful control over the pace of therapy. Under the team’s systematic treatment plan, Mr. Yang’s physical functions gradually recovered and his stamina steadily improved. He progressed from taking independent walks and covering long distances to eventually resuming sports like tennis, successfully shaking off the frailty and confinement to bed that had plagued him for years, and regaining control over his physical well-being.

  04 Enrolling in a cutting-edge CAR-T clinical trial to achieve complete tumor remission

  After chemotherapy stabilized his condition and improved his baseline physical health, a follow-up biopsy revealed that the patient was positive for the CD79b target. Leveraging the hospital’s strengths in cutting-edge clinical research, Mr. Yang successfully enrolled in the department’s clinical trial for CD79b CAR-T cell therapy, marking a major breakthrough in his treatment.
  Following the CAR-T cell infusion, the patient experienced only a transient Grade 1 CRS (Cytokine Release Syndrome) reaction accompanied by a brief fever; the overall treatment process remained safe and manageable, with robust cell expansion. A follow-up assessment one month later showed partial remission (PR). After three months of continued treatment and follow-up, a whole-body PET/CT scan revealed the complete disappearance of all tumor lesions, signifying a successful achievement of complete remission (CR).
  This marked the first time in his nine-year battle against the disease that Mr. Yang achieved the total clearance of systemic lesions, with imaging results showing the best status seen in years.

  05 Reflections on a nine-year battle: Embracing the light, honoring the care received and the original resolve

  After nine years of battling the disease and repeatedly overcoming dire situations, Mr. Yang’s successful outcome is a testament to the precision diagnosis, comprehensive management, and unwavering persistence of the Lymphoma and Myeloma team at Beijing Gaobo Hospital. Facing a complex case characterized by multidrug resistance, a complicated clinical picture, and severe complications, the team utilized their extensive clinical experience, systematic diagnostic approach, and cutting-edge technologies to transcend the limitations of traditional treatments, ultimately securing a chance for clinical cure.
  His long journey fighting the disease taught Mr. Yang a profound lesson: mindset is just as important as medical treatment. There is no need to be overly anxious about fluctuating test markers or to let the illness dictate one’s life; actively adhering to standardized treatment and maintaining a healthy lifestyle are the keys to successfully fighting the tumor. Having recovered and been discharged, Mr. Yang now strictly follows medical advice regarding rest and follow-ups, maintains a regular daily routine, exercises consistently, and cultivates personal interests. By balancing his daily life with his ongoing recovery, he has truly realized the goal of “undergoing treatment for a better life.”
  The patient’s rebirth also owes much to the quiet, steadfast support of his family. Over the years, they have shouldered the burdens of the household—caring for the elderly and raising the children—shielding him from the trivialities of daily life and providing a solid foundation of support. Their companionship and unwavering dedication gave him the strength to battle his illness, helping him endure countless hardships while never losing hope for life.
  After a nine-year ordeal, Mr. Yang has finally overcome recurrent tumors and reclaimed a healthy life. This long journey against cancer stands not only as a vivid testament to the power of medical technology in conquering complex tumors but also as a profound embodiment of perseverance, passion, and the meaning of steadfast support.

  Read more

  • chinameds
  • Uncategorized
• • OCTOBER 5, 2026
  • 0 COMMENTS
  

  New Breakthrough in Post-Stroke Rehabilitation: pBFS Precision Targeting Enables 78-Year-Old Grandmother to Walk Independently Again

  One night six months ago, 78-year-old Grandma Chen (pseudonym) suddenly collapsed due to dizziness and was diagnosed with a cerebral infarction (ischemic stroke). Following the onset, a series of aftereffects ensued, completely disrupting her normal life and plunging her entire family into distress.
  These aftereffects caused Grandma Chen multiple difficulties: she could not lift her right arm or grasp objects with her right hand, her gait was unsteady, and she relied entirely on family members for support when moving about; even basic self-care tasks, such as dressing, became difficult. Furthermore, her speech became slurred, creating significant barriers to communication with her family and drastically reducing her quality of life.
  Rehabilitation for stroke aftereffects has long been a challenge for many patients and their families. Many hold misconceptions, believing that aftereffects manifest solely as hemiplegia (paralysis on one side of the body). In reality, the aftereffects are diverse; beyond hemiplegia, patients may experience limb numbness, swallowing difficulties, depression, and other issues. Since the specific areas of brain damage, symptoms, and severity vary from patient to patient, there is no “one-size-fits-all” rehabilitation plan—a fact that highlights the limitations of traditional rehabilitation therapies.
  Traditional rehabilitation methods for stroke aftereffects have significant shortcomings.
  Clinically, traditional rehabilitation for stroke aftereffects generally falls into two categories, yet both have limitations and struggle to meet the needs of patients with severe impairment.
  The first is conventional rehabilitation training. While this approach can effectively alleviate cerebral edema and improve blood supply to the brain during the acute phase, it cannot fundamentally promote the regeneration of damaged nerves. Consequently, for patients with severe nerve damage, the rehabilitation outcomes are often limited, making it difficult to restore core functions such as limb mobility and speech.
  The second is pharmacological treatment. Medications can alleviate certain symptoms during the early stages of the stroke but cannot repair damaged brain nerves or restore bodily functions. Moreover, long-term medication use carries the risk of side effects, rendering it unsuitable as a standalone method for long-term rehabilitation or the definitive cure of aftereffects. From a medical perspective, the root cause of sequelae such as hemiplegia and aphasia following a cerebral infarction (stroke) is structural damage and functional dysfunction within the brain’s motor networks. Once the neural pathways connecting the cerebral cortex to the spinal cord are damaged, various physiological functions—including limb control, balance, fine motor skills, and speech—become impaired.
  Therefore, the core challenge and key breakthrough in stroke rehabilitation lie in the precise localization of damaged brain regions and the application of targeted interventions.
  A Breakthrough in Precision Medicine: pBFS Technology Maps Personalized “Brain Function”
  In recent years, non-invasive brain stimulation techniques—such as transcranial magnetic stimulation (TMS) and transcranial electrical stimulation (tES)—have emerged as effective new methods for stroke rehabilitation by modulating neuronal excitability and promoting the self-repair of damaged nerves.
  The key to successful rehabilitation lies in accurately identifying intervention targets. Leveraging pBFS (personalized Brain Function Segmentation) technology, clinicians can create a unique “motor cortex target map” for each patient.
  This technology revolutionizes the traditional rehabilitation model—which often relied on trial-and-error based on experience—by enabling millimeter-level precision control. It acts like a precise navigation system for damaged and disordered neural pathways, allowing neuromodulation therapy to target the lesion directly, thereby significantly enhancing rehabilitation efficiency and outcomes.
  A Real-Life Rehabilitation Case: An Elderly Woman Regains Her Ability to Live Independently
  Late last year, Grandma Chen and her family—long troubled by the aftereffects of a stroke—sought professional rehabilitation at Shulan (Hangzhou) Hospital. Addressing her specific condition, the hospital team used functional MRI (fMRI) scans to create a personalized “brain function map,” precisely identify intervention targets, and administer targeted neuromodulation repair therapy.
  After three months of systematic, precision rehabilitation, Grandma Chen’s physical condition improved remarkably, delighting her family. She experienced a significant recovery in speech function, with noticeably clearer articulation and a revitalized mental state. Meanwhile, her motor function has continued to improve: the range of motion in her right arm has largely returned to normal, allowing for flexible forearm rotation; muscle strength in her lower limbs has increased significantly; and her gait has become increasingly steady. Currently, Grandma Chen can walk independently for short distances without family assistance, gradually regaining her ability to manage daily life.
  The aftereffects of cerebral infarction impose a heavy burden on countless patients and their families; Grandma Chen’s recovery offers a beacon of hope to many others facing similar challenges. As precision diagnosis and treatment technologies for brain function continue to evolve, an increasing number of patients with post-stroke sequelae will be able to restore neurological function and reclaim a normal life through scientific, precision-based medical interventions.
  pBFS Educational Spotlight
  01. What is pBFS technology?
  pBFS stands for “Personalized Brain Functional Sub-region Parcellation.” Relying on functional MRI (fMRI) scanning, this technology precisely divides the human brain into over 200 clearly defined functional regions, generating a unique “brain function fingerprint” for each patient. It accurately captures the distinct characteristics of an individual’s brain network, providing a scientific basis for selecting clinical rehabilitation targets and implementing precision interventions.
  02. Which conditions can pBFS treat?
  Currently, pBFS technology is widely used in the clinical rehabilitation of various neurological disorders, including depression, autism, post-stroke hemiplegia, aphasia, Parkinson’s disease, and Alzheimer’s disease. Additionally, cutting-edge clinical research is underway to apply this technology to conditions such as chronic pain and post-traumatic stress disorder (PTSD), with its scope of application continuing to expand.
  03. How does pBFS technology work?
  Personalized Brain Functional Sub-region Parcellation (pBFS) is a technique for segmenting the cerebral cortex into functional regions based on an individual patient’s brain imaging data. By utilizing resting-state functional MRI (fMRI), the technology precisely maps the organization of brain functional networks at the individual level, creating a personalized brain function atlas. By leveraging individual differences in brain function, this technology iteratively identifies precise functional network lesion sites. The resulting functional brain maps demonstrate exceptional reproducibility across individuals while clearly revealing functional heterogeneity among different patients. It enables clinicians to observe human brain function and neural connectivity through the lens of neural circuits, precisely pinpoint areas of functional abnormality, and facilitate efficient, accurate neural intervention and repair—offering vast potential for clinical application.
  04. How does pBFS technology determine treatment targets?
  The medical team acquires patient brain data via functional MRI (fMRI) scans. By monitoring changes in the ratio of oxygenated to deoxygenated hemoglobin, the system precisely captures variations in neuronal metabolic activity and assesses the functional activity levels of various brain regions based on blood-oxygen-level-dependent (BOLD) signals.
  By integrating pBFS individual brain function profiling technology, the system precisely delineates the patient’s unique functional brain zones and quantifies functional connectivity strength and cooperative dynamics between regions. It then correlates these findings with the specific neural circuit abnormalities associated with the patient’s condition and matches them against the biophysical properties of neuromodulation techniques. This process identifies the optimal brain sites—those offering the best intervention efficacy and most stable connectivity—to finalize precise treatment targets and formulate personalized rehabilitation plans.
  05. Contraindications for pBFS technology
  MRI-related scanning is contraindicated for individuals with implanted electronic devices or magnetic metal instruments, such as cochlear implants, cardiac pacemakers, or intracranial aneurysm clips. Patients with a history of epilepsy or those on long-term medication that lowers the seizure threshold are also contraindicated. Pregnant women and patients with severe heart disease require a comprehensive assessment by a specialist to determine the feasibility of the examination and treatment.

  Read more

  • chinameds
  • Uncategorized
• • SEPTEMBER 30, 2026
  • 0 COMMENTS
  

  The First Affiliated Hospital of Xiamen University Successfully Performs Da Vinci Robot-Assisted Single-Port Radical Resection for Rectal Cancer

  Rectal cancer is a prevalent gastrointestinal malignancy. Conventional surgical approaches are associated with significant drawbacks including substantial trauma, limited operative exposure and prolonged recovery. To break through the bottleneck of minimally invasive treatment, the Department of Colorectal Surgery team at The First Affiliated Hospital of Xiamen University performed the first single-port robotic-assisted radical resection of rectal cancer in Fujian Province. This achievement fills the provincial technical gap and delivers an advanced, precise, minimally invasive and cosmetically favorable surgical option for patients with rectal tumors.

  01 Bloody Stool Leads to Tumor Diagnosis, Elderly Patient Faces Surgical Challenges

  A 61-year-old patient, Mr. Dai, presented with bright red hematochezia lasting for 15 consecutive days. After noticing the abnormality, he sought care at a local hospital. Colonoscopy revealed a rectal mass. For definitive and specialized treatment, the patient was referred to the Department of Colorectal Surgery, The First Affiliated Hospital of Xiamen University, under the care of Professor Su Guoqiang, academic leader of the department.

  Digital rectal examination identified a cauliflower-like mass 7 cm from the anal verge, confirming a diagnosis of mid rectal cancer. Further examinations showed the tumor measured approximately 4 cm in diameter. The large tumor size combined with a narrow pelvic cavity created a confined surgical space, rendering conventional surgery highly challenging.

  Constrained by tumor location, lesion size and anatomical conditions, traditional open surgery and multi-port laparoscopic surgery require large incisions and multiple puncture sites. These approaches carry greater trauma, higher risks of postoperative complications and longer recovery periods, imposing severe physical and psychological burdens on patients.

  02 Customized Treatment Plan, MDT Team Overcomes Surgical Barriers

  To achieve complete tumor resection, minimize surgical trauma and preserve postoperative quality of life, Professor Su Guoqiang’s team launched a multidisciplinary team (MDT) consultation. Combined with the patient’s age, tumor characteristics and anatomical features, a tailored plan of single-port robotic-assisted radical rectal cancer resection was formulated.

  Professor Su Guoqiang performed the main operation, with Professor Chen Qionghua, Vice President of the hospital, providing intraoperative guidance. Drawing on extensive experience in robotic single-port gynecologic oncology surgery, the team completed assembly of the single-port access (PORT) system and placement of robotic arms. Adhering strictly to the principle of total mesorectal excision (TME), the team achieved en bloc tumor resection and complete three-field lymph node dissection to meet radical oncological standards.

  Intraoperative blood loss was minimal. Dissection was precise and standardized, and the resected specimen maintained intact mesorectum. The procedure achieved complete eradication of the tumor while preserving anal function, fulfilling both oncological cure and organ preservation goals.

  03 Single-Port Robotic Surgery: Breaking Limitations of Traditional Minimally Invasive Techniques

  Compared with conventional single-port laparoscopy, the da Vinci single-port robotic system eliminates the “chopstick effect” caused by instrument interference, offering prominent advantages for pelvic surgery within confined spaces:

  • Faster establishment of the surgical access and flexible instrument angulation suitable for operations in narrow body cavities
  • Three-dimensional magnified surgical visualization for clear identification of lesions, blood vessels and nerves, improving surgical precision
  • Robotic arms enable dexterous grasping, cutting, hemostasis and suturing, overcoming the physical limitations of human hands
  • Reduced trauma, concealed postoperative scars and accelerated recovery, balancing therapeutic efficacy and cosmetic outcomes

  The operation adopted a 3 cm concealed periumbilical incision. The single-port PORT system supported all surgical steps, specimen extraction and wound management without additional trocar punctures. This technique lowers the risk of abdominal wall incision tumor seeding and reduces postoperative pain associated with multiple trocar sites, aligning with enhanced recovery after surgery principles.

  In addition, robotic surgery enables precise identification and preservation of critical pelvic nerves and blood vessels, substantially reducing the incidence of postoperative urinary and sexual dysfunction to protect patients’ long-term quality of life. The single-port PORT system keeps trocars outside the peritoneal cavity, creating an adequate surgical triangulation. This facilitates thorough abdominal exploration, precise lymph node dissection and expansion of the surgical dissection plane for safer operations.

  04 Rapid Postoperative Recovery Validates Advanced Minimally Invasive Expertise

  Benefiting from precise and minimally invasive manipulation, Mr. Dai recovered smoothly without complications. Successful anal preservation was achieved, and the patient was discharged on postoperative day 6.

  This operation represents the first of its kind performed at The First Affiliated Hospital of Xiamen University, with no relevant literature reported within Fujian Province to date. It marks a new milestone in the hospital’s minimally invasive colorectal oncology program and demonstrates provincial leading technical capability.

  Professional Insight: Rectal Cancer Surgery Enters the Era of Single-Port Robotic Minimally Invasive Treatment

  According to Professor Su Guoqiang, surgical management of rectal cancer has fully entered the minimally invasive era. Conventional laparoscopic rectal cancer surgery requires five trocar punctures, which compromise abdominal aesthetics and raise risks of incision infection, pain and adhesion.

  Although conventional single-port laparoscopy reduces the number of incisions, severe instrument clashing, limited visual field and high technical requirements restrict its widespread adoption.

  The da Vinci single-port robotic platform addresses these challenges. Powered by three-dimensional visualization, wristed robotic instruments and ergonomic human-machine control, it eliminates the “chopstick effect”. It is well suited for rectal cancer surgery with narrow pelvic cavities, deep lesions and limited operative space. It delivers radical resection, minimal trauma, organ preservation, inconspicuous scars and accelerated recovery, serving as a state-of-the-art minimally invasive option for colorectal malignancies.

   

  Read more

  • chinameds
  • Uncategorized

Photostream